Onconetix(ONCO)

Focus: Onconetix is a public oncology diagnostics and treatment company headquartered in Cincinnati, Ohio. The company operates at an early commercial stage with minimal revenue generation to date.

Oncology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Onconetix

AI assessmentNot Hiring

No open roles listed right now. Follow Onconetix to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$3M

FY2025

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

SEC Filings: 2 available

Financials (FY2025)

Revenue

Help build intelligence for Onconetix

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage public company in high-growth oncology segment with potential for significant upside as pipeline matures
Diagnostics focus offers differentiation in oncology market with less crowded competitive landscape than therapeutics
Ground-floor opportunity to build company infrastructure and establish career trajectory in scaling organization

Watch Out For

Severely constrained cash position ($647K as of FY2025) with negative net income of -$58.7M creates imminent sustainability risk
Zero active clinical trials and no identified pipeline programs signal lack of near-term clinical catalysts or revenue drivers
No current job openings and minimal commercial scale suggest limited internal mobility and career development pathways

Generated by Claude from Onconetix's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo